chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SUPPOSED HEART ATTACK; This spontaneous report received from a consumer via social media (J and J Corporate) via a company representative concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) dose, start therapy date were not reported, 01 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, approximately 4 or 5 months post vaccination the patient died from a supposed heart attack. Reporter stated that, "my grandchildren's others grandma took the J&J shot after my daughter-in-law begged her mother not to. She died approximately 4 or 5 months later from a supposed heart attack. They had a closed casket funeral because of something they didn't want others to see after finding her dead several hours later. I don't trust any of these experimental gene altering injections". It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20221240762- Supposed heart attack. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.; Reported Cause(s) of Death: HEART ATTACK
Patient had an allergic reaction. Onsite EMS was called vitals BP 118/82  98%O2  HR 88 Patient refused evaluation or care and released against medical advise.
Received covid booster 10/16/22 end of October started having palpitations mild at first by December increasing in frequency eventually went to doctor diagnosed with atrial flutter and paroxsmal atrial fibrillation underwent ablation
PT STATES SHE DEVELOPED HIVES ON LEGS AND ARMS SHE RECIEVED BOOSTRIX AND MODERNA BIVALENT IMZ ON EVENING OF 5/19/23. SHE TOOK BENADRYL AND HIVES WENT AWAY. SHE STATES SHE WAS FATIGUED ON  5/20/23 AND 5/21/23. ON 5/22/23 SHE EXPERIENCED DIZZINESS, BLURRED VISION, AND NAUSEA WHILE DRIVING. SHORTLY AFTER THOSE SYMPTOMS SHE DEVLOPED A MIGRAINE. ON 5/23/23 SHE IS EXPERIENCING SEVERE BACK PAIN AND SOB.  SHE ASKED IF SHE SHOULD GO TO ER. I TOLD HER TO DO SO IF SHE IS IN THAT MUCH PAIN.
Elevated heart rate: ongoing since 5/22/2021, average resting heart rate is usually in the high 50s-low 60s. 5/22/21 my a average resting heart rate was between 110-120. It has slowly gone down but increases with any type of movement. Jumped to 125 just getting dressed on 5/24/21. Elevated blood pressure: 5/22/21 my blood pressure was 139/80 when my usual rate is around 112-115/60  Contacted doctor and was advised to just monitor.
This case was reported by a pharmacist via call center representative and described the occurrence of myasthenia gravis aggravated in a 82-year-old male patient who received SHINGRIX (batch number G933B, expiry date 22nd November 2020) for prophylaxis. The patient's past medical history included myasthenia gravis. On 27th July 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced myasthenia gravis aggravated (serious criteria GSK medically significant) and double vision. On an unknown date, the outcome of the myasthenia gravis aggravated and double vision were unknown. It was unknown if the reporter considered the myasthenia gravis aggravated and double vision to be related to SHINGRIX. Additional details were provided as follows: The patient was experiencing double vision. The patient noted about having a history of myasthenia gravis and it might be reactivating as a result of the vaccine.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/07/21 ModernaLot# 2nd dose02/04/21 Moderna lot# Diagnosed covid positive:08/02/21 Symptom onset:08/02/21 Exposure:Travel Symptoms:SOB,muscle aches,sore throat
Client was sitting on mother's lap for vaccination. Interpreter present as family speaks another language. Site was cleansed and vaccinations were administered. Client immediately began to cry following vaccination. A few seconds after client began crying and getting worked up, client began having multiple episodes of emesis.  Mom told interpreter that client was "making herself do it." Client had approximately 4-5 episodes of emesis. Emesis was off white in color. Mom reports that client ate right before vaccination appointment. Once client was done vomiting, client was observed in clinic room with RN for 15 minutes following vaccination. Client did have very few petechiae under both eyes following emesis. Mom reports client's face was blotchy, but once client calmed down and stopped crying the blotchiness resolved. Mom was educated on signs and symptoms to look out for and when to seek care prior to leaving clinic appointment. On 10/18/2022 called client's mom with interpreter to see how client was doing. Mom reports that client was doing well and did not even have a fever after vaccination. Recommend client not eat immediately prior to next vaccination appointment. Also explained that client should not have a completely empty stomach. Mom verbalized understanding and did not have any further questions.
This spontaneous report as received from a 64 years old female consumer refers to herself, who was with arthritis and high cholesterol. The patient had drug allergies to sulfa and DAYPRO. In approximately 2009, "about 3 years ago" the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported) under the skin in the arm. "Last week", on 11-OCT-2012, the patient broke out in red welts on her forehead above right eye. So the patient sought for medical attention by going to the public health dept on 12-OCT-2012. The nurse practitioner diagnosed her with shingles and prescribed VALTREX. It was also reported that the patient underwent cholesterol screening "2-3 weeks ago", in approximately September 2012. The patient was already feeling better at the time of reporting. Additional information is not expected.
On 10/3/17 patient called us here at her PCP office to report reaction to flu vaccine she had received at pharmacy. (Pt remembered the vaccine date as 9/25/17 but pharmacy confirmed she had it done on 9/19/17.) Pt reported that 4 days after the vaccine she developed soreness in the arm where she had the vaccine. At the time of her call 10/3/17 pt reported that she had just that day noticed that her arm had a new, very large bruise from deltoid down to the elbow and it appeared to be spreading. Pt takes LOVENOX injections daily so was quite concerned. Pt was advised to have provider evaluate at local urgent care (which she did). Urgent care provider documented the following: "The patient has a large hematoma subcutaneous in her right shoulder in the deltoid muscle area. The patient has ecchymoses inferior to this consistent with blood running downstream in her arm. She does not have any underlying erythema. Nothing at this time to suggest infection." Provider advised pt: "We have found a definite hematoma in your right arm. Given the size, I would guess that this will take 6 weeks to completely reabsorbed. However, it should slowly get smaller over the next 2 weeks.  If you are not allergic to TYLENOL, you may take up to 500 mg every 4 hours as needed for pain. I would recommend 20 minutes of heat off and on. Do not sleep on a heating pad. I would purchase a thermometer. If you have a temperature of 99.5 or higher, I would return for reevaluation to consider infection.
Patient presented to the vaccine to receive COVID 19 vaccine.  The patient was given the Moderna brand of the COVID 19 vaccine which is only approved for patients 18 years of age and older.  No adverse event occurred during the 15 minutes post vaccination waiting perioid.
Menstrual cycle started early and abdominal pressure was way more intense a day before and the day I started my cycle
Patient was given an additional dose of the flu vaccine. Received his last one on 10/13/2021. No adverse reactions.
Numbing in the shoulder tingling like hitting your funny bone but doesn?t go away feels like I just got the shot elbow soreness tingling in fingers
Pain, tenderness, soreness at the injection site; This is a spontaneous report received from a contactable consumer. This consumer reported adverse events with similar suspect for 2 patients. This report is 2nd of two patients. A 49-year-old patient of unspecified gender received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 23 mar 2021 at a single dose for COVID-19 immunisation. The patient's medical history and Concomitant medications were not reported. the patient experienced Pain, tenderness, soreness at the injection site on 24 Mar 2021. The events were resolving on 25 mar 2021.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021344329 same drug, different event and patient
4/7/2021 Diarrhea, cramping, upset stomach, bloody nose  occurred around September 27th ,2021
Patient with Hx of AML received 1st dose COVID vaccine 2/10/2021, 2nd dose 3/4/2021.  She developed DVT of the right leg, AML relapse. The patient has been diagnosed with AML back in 2016 and underwent several lines of therapy including chemotherapy with 7 and 3 and the last treatment was decitabine with maintenance treatment with ivosidenib.  Having severe leukocytosis and right-sided leg edema with DVT raised concern about  blast crisis and leukostasis. Patient was admitted to hospital and received. ceftriaxone and azithromycin for possible pneumonia.  She underwent leukophoresis on the 4/6/2021, 4/7/2021. Patient received IV heparin gtt for DVT but later on was on hold given worsening thrombocytopenia. She was transferred from one hospital to another hospital.  I do not think the development of DVT was due to COVID vaccine. But prior to COVID vaccine, patient was in AML remission.
11/28/2021: Hospital for SOB, prescribed Prednisone 20mg po twice daily x5days, Albuterol nebulizer and  Albuterol inhalers 11/30/2021: Medical facility for continued SOB and leg pain-was told "my body is building antibodies and this is normal" 12/20/2021: ED for continued SOB, Xray completed, negative COVID test, given albuterol nebulizer x3, 12/24/2021: ED for SOB, given nebulizers x3, Prednisone 60mg po  and continued steroid taper for SOB I have had continued shortness of breath with chest discomfort, fatigue and leg pain since taking the vaccine, which has resulted in missed time form work and at times an inability to complete normal daily task
Dizziness. Loss of conscious (few seconds). Feet elevated. Vitals every 10-15 min. Given juice and crackers.
Pt. received Tdap on 9/1/11 - she was also verified to be pregnant on same day. Her estimated due date is 4/2/12. No adverse - we just wanted to report that vaccine was given.
COVID; congestion; headache; fever; fatigue; aches; sore throat; Initial information received on 06-Oct-2021 regarding an unsolicited valid serious case received from a consumer/non health care professional via Regulatory Authority (under the reference 00801151).  This case involves a 57 years old female patient who had covid (covid-19) [Coronavirus Disease] after receiving INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 01-Oct-2021, the patient received a dose of suspect FLUZONE QUADRIVALENT (0.5 ml, lot number and expiration date not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On 05-OCT-2021 the patient developed a serious covid [Coronavirus Disease] (covid-19), congestion (pulmonary congestion), headache, fever (pyrexia), fatigue, aches (pain) and sore throat (oropharyngeal pain), four days later following the administration of vaccine.  This all events was assessed as medically significant.   No laboratory data reported.  The patient was treated with ACETAMINOPHEN and fluids.  At time of reporting, the outcome was unknown for the reported events.   It was reported "Caller states that symptoms started 05-oct-2021 and she went in this morning and diagnosed with rapid test she is still waiting on pcr (polymerase chain reaction) test. Caller states that she is vaccinated for covid (Coronavirus Disease)."  Batch number requested.; Sender's Comments: This case concerns a 57-year-old female patient who had covid-19 [Coronavirus Disease] after vaccination with FLUZONE QUADRIVALENT. The time to onset is compatible. However, patient's medical condition at the time of vaccination and other relevant laboratory data were not reported. Based upon the reported information, the role of a vaccine cannot be assessed.
Injection site red; Injection site painful; Shivering; Breathing very hard; Sweating; Extremely sensitive from head to toe; Diarrhea; Eyes swollen; Tired; This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th December 2019, the patient received Shingrix. In December 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site pain, shivering, difficulty breathing, sweating, sensitive skin, diarrhea, eye swelling and tiredness. On an unknown date, the outcome of the injection site erythema, shivering, difficulty breathing, sweating, sensitive skin, diarrhea and tiredness were unknown and the outcome of the injection site pain and eye swelling were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site pain, shivering, difficulty breathing, sweating, sensitive skin, diarrhea, eye swelling and tiredness to be related to Shingrix.  Additional details were provided as follows: The patient received the Shingrix vaccine and was fine for the first 24 hours. Then the injection site got extremely red and painful and the patient put ice on the injection site for 30 minutes. The patient had severe shivering and was breathing very hard. The patient then went to bed for 1 hour, woke up feeling very cold, went back to bed and then started sweating for the rest of the night. The patient's body was extremely sensitive from head to toe, just by touch. The patient got diarrhea, their eyes became swollen which made him even more tired.  As of 30Dec2019,the patient was still having pain at the injection site and eyes are still a little swollen. The follow up consent was granted.
This case was reported by a pharmacist and described a 3 month old female patient who received hepatitis B vaccine recombinant (Engerix-B) and tested positive for hepatitis B surface antigen.  On 03/18/2004, the patient received the first dose of Engerix-B.  Approximately four days later, on 03/22/2004, laboratory evaluations revealed that the patient tested positive for hepatitis B surface antigen.
Approximately two hours after patient was seen, patient's mother called stating that  patient was seen today for "tetanus shot and now her hand is swollen". A nurse attempted to call patient's mother back to discuss this, but was unable to make contact so left a message advising patient to go to local urgent care for evaluation. I have tried calling patient's mother today to check on patient, but have been unable to reach her at this time.
Pt states he has body aches, fatigue redness and swelling at the site. Pt requested an appointment with primary care provider after being instructed that the side effects are normal for Anthrax. Primary care provider stated they were normal side effects, prescribed Tylenol for symptoms and excused pt from work for the day.
feels like dead weight; aching has grown to the left side of my neck; aching has grown to the left side of my neck and past my arm pit into my left breast; Mouth sores; Covid-19 booster vaccine received; Chills; body aches specifically near spine/slight aches under my left arm pit.; Received my shot on my left arm so soreness; Last night had slight aches under my left arm pit/This morning just woke up with greater soreness in left arm pit, feels like dead weight; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-years-old patient received third dose of bnt162b2 (BNT162B2), administered in arm left, administration date 03Dec2021 (Batch/Lot number: unknown) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunization. Relevant medical history included: "exercise induced asthma" (unspecified if ongoing), notes: Verbatim: exercise induced asthma; "adult acne" (unspecified if ongoing), notes: Verbatim: adult acne; "vertigo" (unspecified if ongoing), notes: Verbatim: vertigo. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE UNKNOWN, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 03Dec2021, outcome "unknown", described as "Covid-19 booster vaccine received"; CHILLS (non-serious) with onset Dec2021, outcome "unknown", described as "Chills"; PAIN (non-serious) with onset Dec2021, outcome "unknown", described as "body aches specifically near spine/slight aches under my left arm pit."; ORAL PAIN (non-serious) with onset 05Dec2021, outcome "unknown", described as "Mouth sores"; PAIN IN EXTREMITY (non-serious) with onset Dec2021, outcome "unknown", described as "Received my shot on my left arm so soreness"; AXILLARY PAIN (non-serious) with onset Dec2021, outcome "unknown", described as "Last night had slight aches under my left arm pit/This morning just woke up with greater soreness in left arm pit, feels like dead weight"; FEELING ABNORMAL (non-serious) with onset 06Dec2021, outcome "unknown", described as "feels like dead weight"; NECK PAIN (non-serious) with onset 06Dec2021, outcome "unknown", described as "aching has grown to the left side of my neck"; BREAST PAIN (non-serious) with onset 06Dec2021, outcome "unknown", described as "aching has grown to the left side of my neck and past my arm pit into my left breast".  Additional Information: Folks were adding a new symptom to COVID booster AE. Last night, the patient had slight aches under her left arm pit. She received shot on her left arm, so soreness by the shot which was different from the aches under her arm pit now. This morning just, she woke up with greater soreness in left arm pit, feels like dead weight. The aching had grown to the left side of her neck and past arm pit into her left breast.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
discomfort a week later; hive at site 3 to 2 inches wide/raised red hive; itchy; A spontaneous report was received from a Consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events discomfort a week later, hive at site 3 to 2 inches wide, raised red hive, itchy..  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number) intramuscularly for prophylaxis of COVID-19 infection.   On unknown date, she experienced discomfort a week later, hive at site 3 to 2 inches wide, raised red  hive, itchy. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  On an unknown date the outcome of events, discomfort a week later, On an unknown date the outcome of events, hive at site 3 to 2 inches wide, On an unknown date the outcome of events, raised red hive, On an unknown date the outcome of events, itchy. was not reported.
sick with a sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sick with a sore throat) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sick with a sore throat). At the time of the report, OROPHARYNGEAL PAIN (sick with a sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
About 36 hours after vaccination I got a red itchy raised rash on left underside of wrist and left rear shoulder.  Lasted a few hours and then went away.; About 36 hours after vaccination I got a red itchy raised rash on left underside of wrist and left rear shoulder.  Lasted a few hours and then went away.; About 36 hours after vaccination I got a red itchy raised rash on left underside of wrist and left rear shoulder.  Lasted a few hours and then went away.; This is a spontaneous report from a non-contactable consumer. A 68-year-old female received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL3248) administered at right arm on an unspecified date Feb2021 09:30 AM as single dose for COVID-19 immunization. The patient was not pregnant. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL3248) administered at left arm on an unspecified date Jan2021 at 08:30 AM as single dose for COVID-19 immunization. The patient medical history included high Blood Pressure, Arthritis, Skin Cancer, Lung Nodule and Liver Cyst. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was allergies to morphine and levofloxacin. Concomitant medications included Lisinopril (LISINOPRIL), Tramadol (TRAMADOL), Gabapentin (GABAPENTIN) and Levothyroxine (LEVOTHYROXINE [LEVOTHYROXINE SODIUM]). On an unspecified date Feb2021 at 09:00 PM, the patient had experienced about 36 hours after vaccination patient got a red itchy raised rash on left underside of wrist and left rear shoulder. Lasted a few hours and then went away. No treatment was given. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. On an unspecified date, the outcome of the events was recovered.  No follow up attempts are possible. No further information is expected.
This spontaneous report as received from a physician via a company representative refers to a 84 year old male patient. No pertinent medical history or drug reactions/allergies were provided. On an unknown date, the patient was vaccinated with ZOSTAVAX refrigerated vial (dose, route and lot number not provided). No co-suspect or concomitant therapies were provided. The physician reported that the patient developed shingles on 2 separate unspecified occasions after receiving ZOSTAVAX vaccine (dates not provided). At the time of the report, the outcome of the event was unknown. Additional information has been requested.
Pt. developed (L) arm erythematous, warmth, tenderness to injection site.